Barclays Starts Zimmer Biomet (ZBH) at Underweight
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $99.19 +1.33%
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 9
Rating Summary:
18 Buy, 26 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 9
Join SI Premium – FREE
Barclays analyst Matt Miksic initiates coverage on Zimmer Biomet (NYSE: ZBH) with a Underweight rating and a price target of $104.00.
For an analyst ratings summary and ratings history on Zimmer Biomet click here. For more ratings news on Zimmer Biomet click here.
Shares of Zimmer Biomet closed at $106.91 yesterday.
You May Also Be Interested In
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
- Piper Sandler Starts Jasper Therapeutics (JSPR) at Overweight
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
